oral glp-1 tirzepatide | Starts at $279/mo Injectable Tirzepatide | Compounded GLP-1/GIP

95% CI: 0.8, 0.9

This pack includes patches that help control appetite, support metabolism, and relieve nausea, ensuring you stay on track with your health goals

Explore the best alternatives to tirzepatide for weight loss, from semaglutide to retatrutide, compounded options, and natural approaches with data.

Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity and related co-morbidities.

Outcomes included total and early-phase (060min) areas under the curve (AUCs) and peak concentrations

For users this could segway into an expansion of the private market and for payers this could provide an affordable entry point for public reimbursement